Wangen (4771) Announces April 2026 Revenue of 420.175 Million Yuan (Year-on-Year Increase of +47.3%)
Key facts
- Wangen (4771) Announces April 2026 Revenue of 420.175 Million Yuan (Year-on-Year Increase of +47.3%)
- Wangen (Stock Code: 4771), in the biotech and medical industry, reported April 2026 revenue of 420.175 million yuan, a significant 47.3% increase year-on-year.
- Source: PR Times
- Date: April 1, 2026
Direct answer
Wangen (Stock Code: 4771), in the biotech and medical industry, reported April 2026 revenue of 420.175 million yuan, a significant 47.3% increase year-on-year.
- Citation
- Wangen (4771) Announces April 2026 Revenue of 420.175 Million Yuan (Year-on-Year Increase of +47.3%) (April 1, 2026), PR Times
- Source
- PR Times
- Date
- April 1, 2026
Wangen (Stock Code: 4771), in the biotech and medical industry, reported April 2026 revenue of 420.175 million yuan, a significant 47.3% increase year-on-year.
📋 Article Processing Timeline
- 📰 Published: April 1, 2026 at 09:00
- 🔍 Collected: May 12, 2026 at 08:00 (983h 0m after Published)
- 🤖 AI Analyzed: May 12, 2026 at 12:04 (4h 4m after Collected)
Wangen (Stock Code: 4771), operating in the biotech and medical industry, announced its revenue for April 2026, totaling 420.175 million yuan. This figure represents a substantial year-on-year increase of 47.3%, indicating strong market demand and potential success of new products.
FAQ
What are the key facts in this article?
Wangen (Stock Code: 4771), in the biotech and medical industry, reported April 2026 revenue of 420.175 million yuan, a significant 47.3% increase year-on-year.
What is the direct answer?
Wangen (Stock Code: 4771), in the biotech and medical industry, reported April 2026 revenue of 420.175 million yuan, a significant 47.3% increase year-on-year.
What is the source and date?
PR Times: https://openapi.twse.com.tw/revenue/twse-rev-4771-11504 | April 1, 2026